Access the full text.
Sign up today, get DeepDyve free for 14 days.
B. Cunha (2001)
Pneumonia in the elderly.Drugs of today, 36 11
T. Hirano, Yingchun Hou, X. Jiao, X. Gu (2003)
Intranasal immunization with a lipooligosaccharide-based conjugate vaccine from nontypeable Haemophilus influenzae enhances bacterial clearance in mouse nasopharynx.FEMS immunology and medical microbiology, 35 1
A. Cripps, J. Kyd (2003)
Bacterial otitis media: Current vaccine development strategiesImmunology and Cell Biology, 81
J. Fomsgaard, A. Fomsgaard, N. Høiby, B. Bruun, C. Galanos (1991)
Comparative immunochemistry of lipopolysaccharides from Branhamella catarrhalis strainsInfection and Immunity, 59
O. Westphal (1965)
Bacterial lipopolysaccharides : extraction with phenol-water and further applications of the procedure, 5
I. Peak, M. Jennings, D. Hood, M. Biserčić, E. Moxon (1996)
Tetrameric repeat units associated with virulence factor phase variation in Haemophilus also occur in Neisseria spp. and Moraxella catarrhalis.FEMS microbiology letters, 137 1
T. Holme, Motiur Rahman, P. Jansson, G. Widmalm (1999)
The lipopolysaccharide of moraxella catarrhalis structural relationships and antigenic properties.European journal of biochemistry, 265 2
A. Zaleski, N. Scheffler, P. Densen, F. Lee, A. Campagnari, B. Gibson, M. Apicella (2000)
Lipooligosaccharide P(k) (Galalpha1-4Galbeta1-4Glc) epitope of moraxella catarrhalis is a factor in resistance to bactericidal activity mediated by normal human serum.Infection and immunity, 68 9
A. Campagnari, S. Spinola, A. Lesse, A. Lesse, Y. Kwaik, R. Mandrell, M. Apicella (1990)
Lipooligosaccharide epitopes shared among gram-negative non-enteric mucosal pathogens.Microbial pathogenesis, 8 5
T. Murphy (1996)
Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune responseMicrobiological Reviews, 60
M. Freudenberg, A. Fomsgaard, I. Mitov, C. Galanos (1989)
ELISA for antibodies to lipid A, lipopolysaccharides and other hydrophobic antigensInfection, 17
S. Sethi, T. Murphy (2001)
Bacterial Infection in Chronic Obstructive Pulmonary Disease in 2000: a State-of-the-Art ReviewClinical Microbiology Reviews, 14
T. Murphy, Aimee Brauer, C. Aebi, S. Sethi (2005)
Identification of Surface Antigens of Moraxella catarrhalis as Targets of Human Serum Antibody Responses in Chronic Obstructive Pulmonary DiseaseInfection and Immunity, 73
B. Catlin (1990)
Branhamella catarrhalis: an organism gaining respect as a pathogenClinical Microbiology Reviews, 3
Ph. D., D. D.G.TerziiskiM. (1991)
Immunoprophylaxis and immunotherapy of gram-negative sepsis and shock with antibodies to core glycolipids and lipid a of bacterial lipopolysaccharidesInfection, 19
Mario Vaneechoutte, G. Verschraegen, G. Claeys, Anne-Marievan Abeele (1990)
Serological typing of Branhamella catarrhalis strains on the basis of lipopolysaccharide antigensJournal of Clinical Microbiology, 28
S. Sethi, N. Evans, B. Grant, T. Murphy (2002)
New strains of bacteria and exacerbations of chronic obstructive pulmonary disease.The New England journal of medicine, 347 7
BA Cunha (2001)
Pneumonia in the elderlyClin Microbiol Infect, 7
K. Oishi, H. Tanaka, F. Sonoda, S. Borann, K. Ahmed, Y. Utsunomiya, K. Watanabe, T. Nagatake, Mario Vaneechoutte, G. Verschraegen, K. Matsumoto (1996)
A monoclonal antibody reactive with a common epitope of Moraxella (Branhamella) catarrhalis lipopolysaccharidesClinical Diagnostic Laboratory Immunology, 3
J. McMichael (2000)
Progress toward the development of a vaccine to prevent Moraxella (Branhamella) catarrhalis infections.Microbes and infection, 2 5
G. Köhler, C. Milstein (1975)
Continuous cultures of fused cells secreting antibody of predefined specificityNature, 256
M. Rahman, A. Jonsson, T. Holme (1998)
Monoclonal antibodies to the epitope alpha-Gal-(1-4)-beta-Gal-(1- of Moraxella catarrhalis LPS react with a similar epitope in type IV pili of Neisseria meningitidis.Microbial pathogenesis, 24 5
Wei-Gang Hu, Jing Chen, J. McMichael, X. Gu (2001)
Functional Characteristics of a Protective Monoclonal Antibody against Serotype A and C Lipooligosaccharides from Moraxella catarrhalisInfection and Immunity, 69
F. Schmitz, A. Beeck, M. Perdikouli, M. Boos, S. Mayer, Sybille Scheuring, K. Köhrer, J. Verhoef, A. Fluit (2002)
Production of BRO β-Lactamases and Resistance to Complement in European Moraxella catarrhalis IsolatesJournal of Clinical Microbiology, 40
C. Verduin, C. Hol, A. Fleer, H. Dijk, A. Belkum (2002)
Moraxella catarrhalis: from Emerging to Established PathogenClinical Microbiology Reviews, 15
Motiur Rahman, A. Jonsson, T. Holme (1998)
Monoclonal antibodies to the epitope α-Gal-(1-4)-β-Gal-(1- ofMoraxella catarrhalisLPS react with a similar epitope in type IV pili ofNeisseria meningitidisMicrobial Pathogenesis, 24
J. McMichael (2000)
Vaccines for Moraxella catarrhalis.Vaccine, 19 Suppl 1
T. Work, E. Work (1969)
Laboratory techniques in biochemistry and molecular biology
T. Murphy (2000)
Vaccine for moraxella catarrhalisVaccine, 19
Shengqing Yu, X. Gu (2005)
Synthesis and Characterization of Lipooligosaccharide-Based Conjugate Vaccines for Serotype B Moraxella catarrhalisInfection and Immunity, 73
J. Gilsdorf, C. Marrs, B. Foxman (2004)
Haemophilus influenzae: Genetic Variability and Natural Selection To Identify Virulence FactorsInfection and Immunity, 72
X. Gu, J. Chen, S. Barenkamp, J. Robbins, C. Tsai, D. Lim, J. Battey (1998)
Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis.Infection and immunity, 66 5
X. Jiao, T. Hirano, Yingchun Hou, X. Gu (2002)
Specific Immune Responses and Enhancement of Murine Pulmonary Clearance of Moraxella catarrhalis by Intranasal Immunization with a Detoxified Lipooligosaccharide Conjugate VaccineInfection and Immunity, 70
A Campbell (1991)
In monoclonal antibody and immunosensor technology. Laboratory techniques in biochemistry and molecular biology, vol. 23
A. Zaleski, N. Scheffler, P. Densen, F. Lee, A. Campagnari, B. Gibson, M. Apicella (2000)
Lipooligosaccharide Pk(Galα1-4Galβ1-4Glc) Epitope of Moraxella catarrhalis Is a Factor in Resistance to Bactericidal Activity Mediated by Normal Human SerumInfection and Immunity, 68
Dexiang Chen, V. Barniak, K. VanDerMeid, J. McMichael (1999)
The Levels and Bactericidal Capacity of Antibodies Directed against the UspA1 and UspA2 Outer Membrane Proteins ofMoraxella (Branhamella) catarrhalis in Adults and ChildrenInfection and Immunity, 67
L. Burman, M. Leinonen, B. Trollfors (1994)
Use of serology to diagnose pneumonia caused by nonencapsulated Haemophilus influenzae and Moraxella catarrhalis.The Journal of infectious diseases, 170 1
I. Mitov, M. Freudenberg, U. Bamberger, C. Galanos (1993)
Cross-binding activity and protective capacity of monoclonal antibodies to lipid A.Immunobiology, 188 1-2
M. Rahman, T. Holme (1996)
Antibody response in rabbits to serotype-specific determinants in lipopolysaccharides from Moraxella catarrhalis.Journal of medical microbiology, 44 5
C. Cunningham (1992)
Monoclonal antibody and immunosensor technology: Ailsa M. Campbell, Elsevier, 1991. Dfl115.00 (pbk) (xxv + 427 pages) ISBN 0 444 81412 4Trends in Biotechnology, 10
Wei-Gang Hu, Jing Chen, J. Battey, X. Gu (2000)
Enhancement of Clearance of Bacteria from Murine Lungs by Immunization with Detoxified Lipooligosaccharide fromMoraxella catarrhalis Conjugated to ProteinsInfection and Immunity, 68
Chris Gallanos, O. Lüderitz, Otto Westhphall (1971)
Preparation and properties of antisera against the lipid-A component of bacterial lipopolysaccharides.European journal of biochemistry, 24 1
Monoclonal antibodies (MAbs) against lipooligosaccharide (LOS) determinants after immunization of BALB/c mice with heat inactivated Moraxella catarrhalis serotype A were generated. MAb 219A9 was specific for a common epitope of A, B, and C M. catarrhalis serotypes in ELISA and immunofluorescent test (IFT). In both tests it also cross-reacted with whole bacteria and LPS antigens isolated from non-typeable H. influenzae and H. parainfluenzae strains. IgM antibody clone 219A9 possessed a strong bactericidal effect against the three serotypes in the presence of complement. Our results demonstrate that antibodies directed to a single LOS epitope common for A, B, and C serotype could be highly protective. This suggests that the common determinants are very promising in the development of LOS-based vaccine against M. catarrhalis. The cross-reactions of MAb 219A9 with Haemophilus spp. also show that immunization could result in immune response to epitopes conserved in other important respiratory pathogens.
Current Microbiology – Springer Journals
Published: Jan 5, 2007
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.